Cerebrovascular disease in type 1A glycogen storage disease

Journal of Clinical Neuroscience

Volumn 5, Issue 1, 1998, Pages 93-94

  Berzsenyi, Mark D ^a,b   Brady, Benjamin M R ^a   O'Donnell, Christopher J ^a   Frayne, Judith H ^a  

^a Rheumatology Unit   (Australia)

^b c/o the Alfred Health Care Group ^*  (Australia)

Author keywords

Basilar artery stenosis; Cerebrovascular disease; Glycogen storage disease

Indexed keywords

EID: 11544249490     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(98)90212-0     Document Type: Article

References (4)

1. Hers H, Van Hoof F, De Barsg T. Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Value D (eds). The Metabolic Basis of Inherited Disease, 6th edn. New York: McGraw-Hill, 1989: 425-437.
2. Beaudet AL. The glycogen storage diseases. In: Wilson JD, Braunwald E, Isselbacher KJ et al (eds). Harrison's Principles of Internal Medicine, 12th edn. New York: McGraw-Hill, 1991: 1854-1860.
3. Levy E, Thibault L, Turgeon J et al. Beneficial effects of fish-oil supplements on lipids, lipoprotein and lipoprotein lipase in patients with glycogen storage disease type 1. Am J Clin Nutr 1993; 57: 922-929.
4. Wolfsdorf JI, Plotkin RA, Laffel LM, Crigler JF. Continuous glucose for the treatment of patients with type 1 glycogen storage disease; comparison of the effects of dextrose and uncooked cornstarch on biochemical variables. Am J Clin Nutr 1990; 52: 1043-1050.